These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 18332151)
1. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Sam S; Coviello AD; Sung YA; Legro RS; Dunaif A Diabetes Care; 2008 Jun; 31(6):1237-41. PubMed ID: 18332151 [TBL] [Abstract][Full Text] [Related]
2. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Yildiz BO; Yarali H; Oguz H; Bayraktar M J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950 [TBL] [Abstract][Full Text] [Related]
3. Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Sam S; Sung YA; Legro RS; Dunaif A Metabolism; 2008 Jan; 57(1):84-9. PubMed ID: 18078863 [TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. Sam S; Legro RS; Bentley-Lewis R; Dunaif A J Clin Endocrinol Metab; 2005 Aug; 90(8):4797-802. PubMed ID: 15899949 [TBL] [Abstract][Full Text] [Related]
5. Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance. Harnois-Leblanc S; Hernandez MI; Codner E; Cassorla F; Oberfield SE; Leibel NI; Mathew RP; Ten S; Magoffin DA; Lane CJ; Goran MI; Azziz R; Baillargeon JP; Geller DH J Clin Endocrinol Metab; 2022 Feb; 107(3):e912-e923. PubMed ID: 34752621 [TBL] [Abstract][Full Text] [Related]
6. Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Baillargeon JP; Carpentier AC Diabetologia; 2007 Dec; 50(12):2424-32. PubMed ID: 17898989 [TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Yilmaz B; Vellanki P; Ata B; Yildiz BO Fertil Steril; 2018 Feb; 109(2):356-364.e32. PubMed ID: 29331234 [TBL] [Abstract][Full Text] [Related]
8. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome. Liu DM; Torchen LC; Sung Y; Paparodis R; Legro RS; Grebe SK; Singh RJ; Taylor RL; Dunaif A Hum Reprod; 2014 Dec; 29(12):2764-72. PubMed ID: 25336708 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome. Karthik S; Vipin VP; Kapoor A; Tripathi A; Shukla M; Dabadghao P Hum Reprod; 2019 Aug; 34(8):1559-1566. PubMed ID: 31299073 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. Coviello AD; Sam S; Legro RS; Dunaif A J Clin Endocrinol Metab; 2009 Nov; 94(11):4361-6. PubMed ID: 19837913 [TBL] [Abstract][Full Text] [Related]
11. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. Legro RS; Kunselman AR; Demers L; Wang SC; Bentley-Lewis R; Dunaif A J Clin Endocrinol Metab; 2002 May; 87(5):2134-8. PubMed ID: 11994353 [TBL] [Abstract][Full Text] [Related]
12. Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS). Lenarcik A; Bidzińska-Speichert B; Tworowska-Bardzińska U; Krępuła K Endokrynol Pol; 2011; 62(2):129-33. PubMed ID: 21528474 [TBL] [Abstract][Full Text] [Related]
13. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. Urbanek M; Sam S; Legro RS; Dunaif A J Clin Endocrinol Metab; 2007 Nov; 92(11):4191-8. PubMed ID: 17785364 [TBL] [Abstract][Full Text] [Related]
14. Metabolic profile in sons of women with polycystic ovary syndrome. Recabarren SE; Smith R; Rios R; Maliqueo M; Echiburú B; Codner E; Cassorla F; Rojas P; Sir-Petermann T J Clin Endocrinol Metab; 2008 May; 93(5):1820-6. PubMed ID: 18230657 [TBL] [Abstract][Full Text] [Related]
15. The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome. Krysiak R; Szkróbka W; Okopień B Pharmacol Rep; 2021 Feb; 73(1):261-268. PubMed ID: 32696349 [TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome. Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734 [TBL] [Abstract][Full Text] [Related]
17. Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome. Sam S; Legro RS; Essah PA; Apridonidze T; Dunaif A Proc Natl Acad Sci U S A; 2006 May; 103(18):7030-5. PubMed ID: 16632599 [TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Yilmaz B; Vellanki P; Ata B; Yildiz BO Fertil Steril; 2018 Aug; 110(3):523-533.e14. PubMed ID: 29960703 [TBL] [Abstract][Full Text] [Related]
19. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome. Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959 [TBL] [Abstract][Full Text] [Related]
20. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]